Show simple item record

dc.contributor.authorRuocco, Gloriaes_ES
dc.contributor.authorCurto, Sergioes_ES
dc.contributor.authorSavio, Maríaes_ES
dc.contributor.authorLaurani, Hildaes_ES
dc.contributor.authorFrocht, Rosaes_ES
dc.date.accessioned2015-08-25T14:54:31Z
dc.date.available2015-08-25T14:54:31Z
dc.date.issued1999es_ES
dc.identifier.citationRuocco, Gloria,Curto, Sergio,Savio, María,Laurani, Hilda,Frocht, Rosa (1999) Vacunación contra Haemophilus influenzae tipo b en el Uruguay: experiencia e impacto. Rev Panam Salud Publica;5(3) -,mar. 1999. Retrieved from http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891999000300021&lng=pt&nrm=isoes_ES
dc.identifier.urihttp://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891999000300021&lng=pt&nrm=isoes_ES
dc.identifier.urihttps://iris.paho.org/handle/10665.2/8952
dc.format.extentiluses_ES
dc.relation.ispartofseriesRev Panam Salud Publica;5(3),mar. 1999es_ES
dc.subjectVacinas Anti-Haemophiluspt_BR
dc.subjectHaemophilus Influenzae Tipo Bes_ES
dc.subjectMeningites Bacterianases_ES
dc.subjectUruguaies_ES
dc.titleVacunación contra Haemophilus influenzae tipo b en el Uruguay: experiencia e impactoes_ES
dc.title.alternativeVaccination against Haemophilus influenzae type b in Uruguay: experience and impacten_US
dc.typeJournal articlesen_US
dc.rights.holderPan American Health Organizationen_US
dc.description.notesBetween 1979 and 1994, epidemiological surveillance of meningitides in Uruguay showed a progressive increase in suppurative meningitides due mainly to Neisseria meningitidis and Haemophilus influenzae type b (Hib). The cases were concentrated in children under 5; however, among the cases caused by Hib, 70 per cent affected children from 1 to 11 months old. Facing this situation, the Ministry of Public Health resolved, as of August 1994, to include the Hib vaccine in the country's Expanded Program on Immunization, which has been in place since 1982. The Hib vaccination is done without charge and is obligatory for all children under 5 years of age. It is done using the following series of vaccinations: a) three doses, given at 2, 4, and 6 months, with a booster dose at age 1; b) children from 7 to 11 months old receive two doses two monts apart and a booster dose a year later; and c) a single dose for children 12 months to 4 years old. Between August and December 1994 a coverage rate of 76.6 per cent was reached among children between 2 months and 4 years old, and the coverage has remained above 80 per cent in the new cohorts. In Uruguay, this vaccination strategy had a spectacular impact on morbidity and mortality due to meningitides caused by Hib. One of the results was that the incidence of 15.6 per 100 000 registered in children under 5 in the prevaccination years declined to 0.03 per 100 000 in 1996en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record